Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 137 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Community-Acquired Infections Clear all

Conditions: Abscess
Interventions: Septra; Drug
Lead sponsor: 59th Medical Wing; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Lackland Air Force Base, Texas

Conditions: Community-acquired Bacterial Pneumonia
Interventions: Solithromycin, Moxifloxacin, Placebo to match solithromycin; Drug · Other
Lead sponsor: Melinta Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 25
States / cities: Glendale, California • Los Angeles, California • Mission Hills, California + 18 more

Conditions: Pneumonia, Community Acquired Pneumonia, Hospital Acquired Pneumonia, Acute Lung Injury
Interventions: ticagrelor, placebo; Drug
Lead sponsor: University of Kentucky; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Lexington, Kentucky

Conditions: Adult Women Living With HIV/AIDS, Intimate Partner Violence
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Staphylococcus Aureus, Community-acquired Infections, Staphylococcal Skin Infections
Interventions: 2% chlorhexidine gluconate (CHG) impregnated cloths, Comfort Bath cloths (placebo cloths); Drug
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 35 Years
Enrollment: 1,563 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Quantico, Virginia

Conditions: Sepsis, Community Acquired Pneumonia (CAP)
Interventions: OPT101, Placebo; Drug · Other
Lead sponsor: Op-T LLC; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Community-Acquired Pneumonia (CAP)
Interventions: Receipt of PCV20; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 19 Years and older
Enrollment: 846,279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Skin Diseases, Infectious
Interventions: Trimethoprim-sulfamethoxazole, Placebo group; Drug
Lead sponsor: St. Louis University; Other
Eligibility: 3 Months to 18 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Lung Transplant Infection
Interventions: Inhaled beclomethasone, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Community-acquired Pneumonia, COPD Exacerbation Acute
Interventions: neuromuscular electrical stimulation (NMES); Device
Lead sponsor: University of Vermont; Other
Eligibility: 50 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Tuberculosis (TB), Tuberculosis Infection, Latent, HIV (Human Immunodeficiency Virus)
Interventions: Mobile chest radiography for tuberculosis screening; Diagnostic Test
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Pneumonia, Bacterial
Interventions: Sulopenem and PF-03709270, Ceftriaxone and amoxicillin/clavulanate; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 12
States / cities: Chula Vista, California • Oceanside, California • Moline, Illinois + 4 more

Conditions: Community-acquired Infection
Interventions: GSK2251052; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Adherence, Patient, TB, HIV/AIDS, Care Coordination
Interventions: CHW mHealth patient intervention for trigger escalation; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pneumonia
Interventions: Not listed
Lead sponsor: David Grant U.S. Air Force Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Travis Air Force Base, California

Conditions: Bacterial Pneumonia
Interventions: Ceftaroline fosamil for Injection, IV Ceftriaxone, Placebo, Clarithromycin; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 606 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 12
States / cities: Los Angeles, California • Pasadena, California • Sacramento, California + 9 more

Conditions: Complicated Intra-abdominal Infection
Interventions: TP-434, Ertapenem, Placebo; Drug
Lead sponsor: Tetraphase Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 5
States / cities: Long Beach, California • Denver, Colorado • Detroit, Michigan + 2 more

Conditions: HIV/AIDS and Infections
Interventions: POSSE; Behavioral
Lead sponsor: Cook County Health; Government
Eligibility: 15 Years to 25 Years · Male only
Enrollment: 1,037 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Chicago, Illinois • Philadelphia, Pennsylvania

Conditions: HIV/AIDS
Interventions: CHW Sessions, CleverCap; Behavioral · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 5
States / cities: Hobson City, Alabama • Opelika, Alabama • New Orleans, Louisiana + 1 more

Conditions: Hiv, Mental Health Issue, Support, Family
Interventions: MPowerment PrEP Promotion Intervention; Behavioral
Lead sponsor: George Mason University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Enterobacteriaceae Infections, Community-Acquired Infections, Healthcare Associated Infection, Carbapenem-Resistant Enterobacteriaceae Infection
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 99 Years
Enrollment: 2,172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Community Acquired Bacterial Pneumonia
Interventions: Efficacy of ceftaroline; Drug
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Albany, New York

Conditions: Community-Acquired Pneumonia, Antimicrobial Stewardship, Point-of-Care Testing
Interventions: Rapid Diagnostic Testing, Pharmacist-led de-escalation; Diagnostic Test · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 28,580 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 12
States / cities: Vero Beach, Florida • Weston, Florida • Akron, Ohio + 8 more

Conditions: HIV Infections
Interventions: Printed materials, Peer advocates; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 12 Years to 24 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 6
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 3 more

Search by objective public record fields.

Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor

Clinic-Community Bridge to Improve Health Outcomes for Abused Women Living With HIV/AIDS

Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates

OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia

Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management

Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients

Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia

Screening With Portable X-rays for Rapid Recognition of TB

A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization

An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects

Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA

Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

POSSE Project: A Community-Level Intervention for Black YMSM

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

PrEP Intervention in Prince George's County, Maryland

Community-associated Highly-Resistant Enterobacterales

Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia

Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia

C2P - Phase III: MPowerment and Community Promise